Test ID CARTA Carbamazepine, Total, Serum
Useful For
Monitoring therapy
Determining compliance
Assessing toxicity
Method Name
Homogeneous Microparticle Agglutination Immunoassay
Reporting Name
Carbamazepine, Tot, SSpecimen Type
Serum RedOrdering Guidance
This test measures carbamazepine only. For assessment of its active metabolite, carbamazepine-10,11-epoxide, which is the predominant form in children, order CARBG / Carbamazepine-10,11-Epoxide, Serum)
Specimen Required
Collection Container/Tube: Red top
Specimen Volume: 0.5 mL
Submission Container/Tube: Plastic vial
Collection Instructions: Centrifuge and aliquot serum into a plastic vial within 2 hours of collection.
Specimen Minimum Volume
0.25 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum Red | Refrigerated (preferred) | 7 days | |
Frozen | 28 days | ||
Ambient | 48 hours |
Reference Values
Therapeutic: 4.0-12.0 mcg/mL
Critical value: ≥15.0 mcg/mL
Day(s) Performed
Monday through Sunday
Report Available
Same day/1 dayPerforming Laboratory
Mayo Clinic Laboratories in RochesterTest Classification
This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.CPT Code Information
80156
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
CARTA | Carbamazepine, Tot, S | 3432-2 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
CARTA | Carbamazepine, Tot, S | 3432-2 |
NY State Approved
YesForms
If not ordering electronically, complete, print, and send 1 of the following forms with the specimen:
-Neurology Specialty Testing Client Test Request (T732)
-Therapeutics Test Request (T831)